AMP Introduced All-In-One Facial AquaFirmeXS

Aesthetic Medical Partnership (AMP) has launched AquaFirmeXS, a second-generation multifunctional dermal health workstation that cleanses, exfoliates, hydrates and nourishes the skin to treat a variety of concerns from pigmentation, blemishes and textural irregularities to dullness, dehydration and hair and scalp health. AquaFirmeXS uses three handpieces – EVO, Exo2 and ULTRA – along with proprietary aqua-photonics technology to deeply yet gently cleanse and exfoliate the skin before nutrients are delivered deep into the skin.

Powered by patent-protected EXO|E technology, the vegan-friendly AquaFirmeXS serums correspond to the skin’s needs and are specifically designed to revitalise and defend against ageing. 

In addition, AquaFirmeXS can be used as a needle-free delivery system for AMP’s unique plant-derived exosomes. It can be painlessly used to treat hair and scalp health concerns with a unique combination of DE|RIVE and ULTRA technology to deliver the hair-specific exosome growth factors to the follicular depth. These topicals are specifically designed to nourish the scalp and support hair health. While the inflammation-reducing and elastin, collagen, and HA-boosting EXO|E exosomes can be delivered more deeply into the skin with the ULTRA applicator for facial treatments.

To find out more, visit https://amp-uk.co.uk or call 07734 101 275 or 07867 397 106.

About AMP

Aesthetic Medical Partnership (AMP) was founded by Martyn Roe and Paul Simmonds, long-term friends who have more than four decades of experience in the aesthetics sector.

Collectively, they have unrivalled knowledge and expertise in what makes a successful product or treatment and how technology and ingredients can work to elevate the services of an aesthetic clinic.

Martyn’s career has spanned sales, clinic ownership, and distribution, as well as providing specialised consultancy services for individual clinics to help them develop their practices.

He has spearheaded launches for several high-profile companies and brands, such as Allergan (bringing Botox® to the UK), Wigmore Medical, Merz, Teoxane, Deka, ABC Lasers and SkinBrands, as well as the introduction and distribution of HydraFacial to the UK market until its sale to HydraFacial in 2019 and continuing to manage the UK operation until 2021.

Paul’s career has also encompassed roles, primarily in sales but also as a service engineer, within some of the UK’s largest aesthetics companies, including HydraFacial and Syneron Candela.